Elaine Caughey, MBA
Chief Business Officer, Cygnal Therapeutics
Elaine joined Cygnal in 2019 as Chief Business Officer. She brings to Cygnal 20 years of experience in corporate and growth strategy, organizational operations, partnerships, and business development.
Prior to joining Cygnal, Elaine worked as a consultant to The Blackstone Group, a private equity group, where she invested in late-stage life sciences companies. Previously, Elaine spent a number of years at Biogen as Senior Director of Business Development, where she executed partnerships in oncology and led several in-licensing partnerships and acquisitions to expand Biogen’s immunology pipeline. She also served as Head of Strategy and Operations, Global Market Access, building the market access and pricing teams within Biogen as well as taking part in commercial drug launches in multiple sclerosis, hemophilia, and neurodegeneration. Prior to Biogen, she worked in business development and corporate venture at CYTYC Corporation, which was acquired by Hologic. Elaine spent the early part of her career in venture capital, playing an important role in incubating companies as well as driving investments in early-stage biotech and device startups.
Elaine holds her BA in economics from Wellesley College and her MBA from Harvard Business School.